Nancy A Simonian - Net Worth and Insider Trading
Nancy A Simonian Net Worth
The estimated net worth of Nancy A Simonian is at least $864 dollars as of 2024-12-26. Nancy A Simonian is the Director of Syros Pharmaceuticals Inc and owns about 4,000 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $864. Details can be seen in Nancy A Simonian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy A Simonian has not made any transactions after 2024-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nancy A Simonian
Nancy A Simonian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy A Simonian owns 4 companies in total, including Evelo Biosciences Inc (EVLO) , Seagen Inc (SGEN) , and Syros Pharmaceuticals Inc (SYRS) among others .
Click here to see the complete history of Nancy A Simonian’s form 4 insider trades.
Insider Ownership Summary of Nancy A Simonian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVLO | Evelo Biosciences Inc | 2018-05-08 | director |
| SGEN | Seagen Inc | 2019-05-20 | director |
| SYRS | Syros Pharmaceuticals Inc | 2024-12-02 | director & 10 percent owner & President & CEO |
 | | 2010-05-13 | director |
Nancy A Simonian Latest Holdings Summary
Nancy A Simonian currently owns a total of 1 stock. Nancy A Simonian owns 4,000 shares of Syros Pharmaceuticals Inc (SYRS) as of December 2, 2024, with a value of $864.
Latest Holdings of Nancy A Simonian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-12-02 | 4,000 | 0.22 | 864 |
Holding Weightings of Nancy A Simonian
Nancy A Simonian Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy A Simonian has made a total of 2 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 37,070 shares on December 2, 2024, which brought Nancy A Simonian around $10,009.
Insider Trading History of Nancy A Simonian
- 1
Nancy A Simonian Trading Performance
Nancy A Simonian Ownership Network
Nancy A Simonian Owned Company Details
What does Evelo Biosciences Inc do?
Who are the key executives at Evelo Biosciences Inc?
Nancy A Simonian is the director of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .
Evelo Biosciences Inc (EVLO) Insider Trades Summary
Over the past 18 months, Nancy A Simonian made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 13,391 shares made by Duncan Mchale , a net sale of 13,145 shares made by Mark Bodmer , and a net sale of 7,814 shares made by Marella Thorell .
In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,860 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,374,395 shares.
Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evelo Biosciences Inc Insider Transactions
Nancy A Simonian Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy A Simonian. You might contact Nancy A Simonian via mailing address: C/o Syros Pharmaceuticals, Inc., 620 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
